Clinical Assessment Note

Specialty of Clinician: Addiction Medicine Specialist Clinical Assessment Note Chief Complaint: "I'm here because I can't stop using crystal meth, and it's ruining my life." History of Present Illness: Patient, a 35-year-old male, presents with a chief complaint of uncontrollable crystal methamphetamine use. He reports daily use for the past 2 years, escalating in frequency and quantity over the last 6 months. He typically smokes the drug multiple times a day, starting in the morning and continuing until late evening. He experiences intense cravings, particularly in stressful situations. He has attempted to quit on several occasions, lasting no more than a few days, experiencing severe withdrawal symptoms including extreme fatigue, dysphoria, anhedonia, increased appetite, and vivid, unpleasant dreams. These symptoms typically lead to relapse. He reports significant impact on his employment, relationships, and financial stability. Symptoms: * Intense cravings for crystal methamphetamine * Withdrawal symptoms: fatigue, dysphoria, anhedonia, increased appetite, vivid dreams * Psychological dependence: preoccupation with drug-seeking, difficulty cutting down * Social isolation: estrangement from family and friends * Financial distress: due to drug use * Aggravating factors: stress, boredom, peer pressure * Alleviating factors: none reported during attempts to quit, temporary relief with drug use Past Medical History: * Depression, diagnosed 5 years ago, intermittently managed with escitalopram, currently not taking medication. * Anxiety disorder, history of panic attacks. * Childhood asthma, well-controlled. Medical Investigations: No formal medical investigations related to substance use have been performed. Patient reports a negative HIV test 6 months ago. Treatment Completed: Patient has attempted self-detoxification several times without medical supervision. He attended one NA meeting 3 months ago but did not continue. Future Treatment Plans: * Initiate outpatient detoxification protocol, potentially including pharmacological support for withdrawal management. * Referral for individual psychotherapy, focusing on cognitive behavioural therapy (CBT) and motivational interviewing (MI). * Referral to a local Narcotics Anonymous (NA) group for ongoing peer support. * Discuss potential adjunctive pharmacotherapy for co-occurring depression and anxiety. * Develop a relapse prevention plan. Future Medical Appointments: * Follow-up with Addiction Medicine Specialist in 1 week (08 November 2024). * Initial appointment with recommended psychotherapist within 2 weeks. * Appointment for comprehensive physical exam and routine blood work within 4 weeks. Medications: * No current prescribed medications. Patient reports occasional use of ibuprofen for headaches. Allergies: * Penicillin (rash) Social History: Patient is single and lives alone in a rented flat. He was formerly employed as a graphic designer but lost his job 3 months ago due to absenteeism related to drug use. He reports a history of tobacco smoking (10 cigarettes/day for 15 years) and occasional alcohol use, denying recent heavy drinking. He denies intravenous drug use. His living situation is stable but he is experiencing financial difficulties. He has limited social support, having alienated many friends and family members. Functional Capacity and ADLs: The patient's condition significantly impacts his activities of daily living. His personal hygiene has declined, with infrequent showering and neglect of appearance. Domestic chores are largely undone, leading to a cluttered and unhygienic living environment. His mobility is generally unimpaired, but he reports extreme fatigue and lack of motivation, making daily tasks challenging. He no longer drives as his license was suspended due to a drug-related incident. His sleep pattern is severely disrupted, characterised by insomnia during active use and hypersomnia during withdrawal periods. Family History: * Father: History of alcohol dependence. * Mother: History of anxiety and depression. * Maternal uncle: History of heroin use. Review of Systems: * General: Reports fatigue, weight loss (approx. 5kg in last 3 months), decreased energy. * Psychiatric: Reports anhedonia, low mood, anxiety, irritability, poor concentration, insomnia/hypersomnia. Denies suicidal ideation but reports feeling hopeless. * Cardiovascular: Denies chest pain, palpitations. Heart rate 88 bpm, BP 130/80 mmHg. * Respiratory: Denies cough, shortness of breath. Lungs clear to auscultation. * Gastrointestinal: Reports decreased appetite, occasional nausea. Bowel habits regular. * Musculoskeletal: Denies joint pain, muscle aches. * Neurological: Denies seizures, numbness, tingling. Reports occasional headaches. Physical Examination: * Vital Signs: BP 130/80 mmHg, HR 88 bpm, RR 16 breaths/min, Temp 36.8°C, BMI 21. * General: Appears fatigued, slightly dishevelled. Oriented to person, place, time. Speech coherent, affect constricted. * HEENT: Pupils equal, round, reactive to light. No scleral icterus or conjunctival pallor. Oral mucosa dry. * Cardiovascular: Regular rate and rhythm, no murmurs. * Respiratory: Clear to auscultation bilaterally, no wheezes or crackles. * Abdomen: Soft, non-tender, non-distended, normoactive bowel sounds. * Extremities: No oedema, cyanosis, clubbing. No track marks noted. * Neurological: Cranial nerves intact. Motor strength 5/5 bilaterally. Sensory intact. Reflexes 2+ bilaterally. Assessment: Patient presents with severe stimulant use disorder (crystal methamphetamine type), consistent with DSM-5 criteria. Co-occurring depression and anxiety are noted. Withdrawal symptoms are significant, indicating physiological dependence. Patient expresses a desire for change and is seeking treatment. Plan: * Admit to outpatient addiction programme with daily attendance for initial detoxification and stabilisation. * Prescribe benzodiazepine taper (e.g., diazepam) for withdrawal symptom management, as clinically indicated. * Begin supportive counselling focusing on motivational enhancement and psychoeducation regarding addiction. * Referral to a psychiatrist for evaluation and management of co-occurring mood and anxiety disorders. * Arrange an appointment with a social worker to address housing, employment, and financial concerns. * Follow-up with Addiction Medicine Specialist in one week for medication review and progress assessment. * Advise patient to abstain from all illicit substances and alcohol. Provide resources for NA meetings and crisis support numbers.